Revvity Signals Software, Inc.

Revvity Signals Software, Inc. Signals Division, a division of Revvity Inc. headquartered in Waltham, Massachusetts, is a scientific informatics software vendor delivering prime-contract electronic laboratory notebooks, chemical structure drawing and analysis tools, and data visualization platforms to federal research agencies on full-and-open, non-set-aside basis. The vendor operates as a 100% prime contractor (279 awards of 280 total), competing exclusively outside set-aside categories. Revvity Signals holds subsidiary status under parent company Revvity Inc., a for-profit corporation that also delivers laboratory equipment and analytical instrumentation to federal agencies.

Revvity Signals' customer base concentrates heavily in the National Institutes of Health ecosystem. The top five customer agencies by combined potential value account for 62% of dollars: the National Center for Advancing Translational Sciences (13 awards, $6.4 million), the National Institute on Drug Abuse (35 awards, $834 thousand), the Defense Health Agency (5 awards, $497 thousand), the Naval Air Warfare Center (15 awards, $440 thousand), and the Department of the Army Medical Command (10 awards, $400 thousand). By award count, NIDA leads with 35 awards, followed by Naval Air Warfare Center and NIAID, each with 15 awards. The two rankings diverge on dollars: NCATS anchors most of the value despite fewer awards, reflecting its single large-dollar definitive contract and multi-year software renewal orders, while NIDA and NIAID generate substantial volume through serial, lower-dollar purchase orders for seat licenses and maintenance services.

The vendor's capability portfolio centers on licensed software products: ChemOffice (chemical structure drawing and analysis), ChemDraw (specialized chemical drawing tools), Signals Notebook and Signals Image Artist (electronic laboratory notebook platforms), Columbus (data visualization and analysis), and Oracle Cartridge (chemical knowledge integration for enterprise platforms). Representative prime work includes a $2,007,319.81 definitive contract from the National Center for Advancing Translational Sciences in September 2026 to obtain FedRAMP Moderate authorization for the Revvity Signals electronic laboratory notebook supporting chemistry-focused research; a $2,577,775.08 purchase order from NCATS in May 2023 for renewal of PerkinElmer Informatics software (ChemOffice, ChemDraw, Signals Notebook, Columbus) running through March 2026; and a $180,682.40 purchase order from Naval Air Warfare Center in November 2023 for ChemOffice software licensing covering base year and four option years through December 2028. Most awards are firm-fixed-price purchase orders carrying one-year to multi-year performance periods; software maintenance, installation, training, and data migration services appear as add-ons to license orders.

Activity has remained modest and volatile. The vendor logged 12 awards in 2021, 11 in 2022, 16 in 2023, 5 in 2024, and 2 awards through September 2026. The source does not characterize this pattern as growth, decline, or flat. Combined potential value across 280 awards stands at $13.8 million, with $13.3 million obligated (96% realization rate). Three awards with ultimate completion dates in the next twenty-four months carry combined potential value of $2.2 million, presenting recompete exposure limited in scale.

Revvity Signals maintains minimal subcontract activity: only one sub-award appears in the source (a January 2023 sub to Battelle Memorial Institute for chemical threat-analysis software renewal supporting Army Combat Capabilities Development Command Chemical Biological Center). Service Contract Inventory data captured only three SCI records, all as named subcontractor, spanning FY2022–FY2025 and totaling 1.6 FTEs across those years — a signal that most Revvity Signals federal work remains below the SCI reporting threshold or operates outside the contract-labor service category that SCI tracks. The vendor operates as a pure software-licensing and maintenance vendor, not a labor-intensive services prime.

Revvity Signals competes only on full-and-open solicitations; no awards carry 8(a), HUBZone, SDVOSB, or other set-aside designations. Its award distribution spans 50 distinct customer agencies, but NIH components and Defense Health Agency comprise the plurality of dollars and awards. The vendor does not sit on named GWACs, BPAs, or government-wide IDIQs in the source record; its presence on the Information Analysis Center Multiple-Award Contract appears limited to a single task order.